Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
April 29, 2016
Absorption, distribution, metabolism and elimination of 14C-ETX0914, a novel inhibitor of bacterial type-II topoisomerases in rodents
Jian Guo, Camil Joubran, Ricardo A Luzietti, et al.
ACS Medicinal Chemistry Letters
|
July 19, 2023
Anti-infectives Developed as Racemic Drugs in the 21st Century: Norm or Exception?
Diego González Cabrera, Dennis A Smith, Gregory S Basarab, et al.
ACS Infectious Diseases
|
September 23, 2020
Structural Basis for Inhibitor Potency and Selectivity of <i>Plasmodium falciparum</i> Phosphatidylinositol 4-Kinase Inhibitors
Stephen Fienberg, Charles J Eyermann, Lauren B Arendse, et al.
Journal of Medicinal Chemistry
|
February 3, 2022
Probing the Requirements for Dual Angiotensin-Converting Enzyme C-Domain Selective/Neprilysin Inhibition
Lauren B Arendse, Gyles E Cozier, Charles J Eyermann, et al.
Journal of Medicinal Chemistry
|
April 1, 2025
Design of Novel Mercapto-3-phenylpropanoyl Dipeptides as Dual Angiotensin-Converting Enzyme C-Domain-Selective/Neprilysin Inhibitors
Gyles E Cozier, Lauren B Coulson, Charles J Eyermann, et al.
Journal of Medicinal Chemistry
|
October 7, 2014
Novel DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole scaffold: SAR and in vivo characterization
Gregory S Basarab, Patrick Brassil, Peter Doig, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
Investigating Sulfoxide-to-Sulfone Conversion as a Prodrug Strategy for a Phosphatidylinositol 4-Kinase Inhibitor in a Humanized Mouse Model of Malaria
Liezl Gibhard, Mathew Njoroge, Tanya Paquet, et al.
ACS Infectious Diseases
|
September 14, 2016
Illicit Transport via Dipeptide Transporter Dpp is Irrelevant to the Efficacy of Negamycin in Mouse Thigh Models of Escherichia coli Infection
David C McKinney, Natascha Bezdenejnih-Snyder, Krista Farrington, et al.
Journal of Medicinal Chemistry
|
October 9, 2013
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents
Gregory S Basarab, John I Manchester, Shanta Bist, et al.
Journal of Medicinal Chemistry
|
September 11, 2020
Antibacterial Spiropyrimidinetriones with N-Linked Azole Substituents on a Benzisoxazole Scaffold Targeting DNA Gyrase
Gregory S Basarab, Peter Doig, Charles J Eyermann, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
April 29, 2016
Absorption, distribution, metabolism and elimination of 14C-ETX0914, a novel inhibitor of bacterial type-II topoisomerases in rodents
Jian Guo, Camil Joubran, Ricardo A Luzietti, et al.
ACS Medicinal Chemistry Letters
|
July 19, 2023
Anti-infectives Developed as Racemic Drugs in the 21st Century: Norm or Exception?
Diego González Cabrera, Dennis A Smith, Gregory S Basarab, et al.
ACS Infectious Diseases
|
September 23, 2020
Structural Basis for Inhibitor Potency and Selectivity of <i>Plasmodium falciparum</i> Phosphatidylinositol 4-Kinase Inhibitors
Stephen Fienberg, Charles J Eyermann, Lauren B Arendse, et al.
Journal of Medicinal Chemistry
|
February 3, 2022
Probing the Requirements for Dual Angiotensin-Converting Enzyme C-Domain Selective/Neprilysin Inhibition
Lauren B Arendse, Gyles E Cozier, Charles J Eyermann, et al.
Journal of Medicinal Chemistry
|
April 1, 2025
Design of Novel Mercapto-3-phenylpropanoyl Dipeptides as Dual Angiotensin-Converting Enzyme C-Domain-Selective/Neprilysin Inhibitors
Gyles E Cozier, Lauren B Coulson, Charles J Eyermann, et al.
Journal of Medicinal Chemistry
|
October 7, 2014
Novel DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole scaffold: SAR and in vivo characterization
Gregory S Basarab, Patrick Brassil, Peter Doig, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
Investigating Sulfoxide-to-Sulfone Conversion as a Prodrug Strategy for a Phosphatidylinositol 4-Kinase Inhibitor in a Humanized Mouse Model of Malaria
Liezl Gibhard, Mathew Njoroge, Tanya Paquet, et al.
ACS Infectious Diseases
|
September 14, 2016
Illicit Transport via Dipeptide Transporter Dpp is Irrelevant to the Efficacy of Negamycin in Mouse Thigh Models of Escherichia coli Infection
David C McKinney, Natascha Bezdenejnih-Snyder, Krista Farrington, et al.
Journal of Medicinal Chemistry
|
October 9, 2013
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents
Gregory S Basarab, John I Manchester, Shanta Bist, et al.
Journal of Medicinal Chemistry
|
September 11, 2020
Antibacterial Spiropyrimidinetriones with N-Linked Azole Substituents on a Benzisoxazole Scaffold Targeting DNA Gyrase
Gregory S Basarab, Peter Doig, Charles J Eyermann, et al.
Page
of 5